Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changhoon Yoo

Showing results (131-140 of 250) with videos related to

Pageof 25
Sort By:
Journal of Hepato-Biliary-Pancreatic Sciences|June 3, 2022
Prediction of margin-negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: Diagnostic performance of NCCN criteria for resection vs CT-determined resectabilityJong Keon Jang, Se Jin Choi, Jae Ho Byun, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2021
Corrigendum to 'Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer', [Eur J Canc 51 (2015) 482-488]Min-Hee Ryu, Changhoon Yoo, Jong Gwang Kim, et al.
Cancer Research and Treatment|February 5, 2015
A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast CancerChanghoon Yoo, Sung-Bae Kim, Jin-Hee Ahn, et al.
Annals of Surgical Oncology|November 29, 2024
ASO Author Reflections: Prognostic Value of NCCN Criteria for Resection Following Neoadjuvant Therapy in Localized Pancreatic CancerJong Keon Jang, Jae Ho Byun, Se Jin Choi, et al.
Cancer Medicine|January 30, 2019
Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experienceJwa Hoon Kim, Min-Hee Ryu, Changhoon Yoo, et al.
Liver Cancer|May 12, 2021
Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective StudyChanghoon Yoo, Jwa Hoon Kim, Min-Hee Ryu, et al.
American Journal of Hematology|June 16, 2007
Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in KoreaChanghoon Yoo, Min-Hee Ryu, Jooryung Huh, et al.
Annals of Surgical Oncology|November 1, 2024
Survival Outcomes According to NCCN Criteria for Resection Following Neoadjuvant Therapy for Patients with Localized Pancreatic CancerJong Keon Jang, Jae Ho Byun, Se Jin Choi, et al.
Future Oncology (London, England)|July 29, 2022
Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenibDong-Hoon Lim, Andrea Casadei-Gardini, Myung Ah Lee, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2016
Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumorChanghoon Yoo, Hyungwoo Cho, Min Jeong Song, et al.
Pageof 25

Showing results (131-140 of 250) with videos related to

Sort By:
Pageof 25
Journal of Hepato-Biliary-Pancreatic Sciences|June 3, 2022
Prediction of margin-negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: Diagnostic performance of NCCN criteria for resection vs CT-determined resectabilityJong Keon Jang, Se Jin Choi, Jae Ho Byun, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2021
Corrigendum to 'Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer', [Eur J Canc 51 (2015) 482-488]Min-Hee Ryu, Changhoon Yoo, Jong Gwang Kim, et al.
Cancer Research and Treatment|February 5, 2015
A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast CancerChanghoon Yoo, Sung-Bae Kim, Jin-Hee Ahn, et al.
Annals of Surgical Oncology|November 29, 2024
ASO Author Reflections: Prognostic Value of NCCN Criteria for Resection Following Neoadjuvant Therapy in Localized Pancreatic CancerJong Keon Jang, Jae Ho Byun, Se Jin Choi, et al.
Cancer Medicine|January 30, 2019
Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experienceJwa Hoon Kim, Min-Hee Ryu, Changhoon Yoo, et al.
Liver Cancer|May 12, 2021
Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective StudyChanghoon Yoo, Jwa Hoon Kim, Min-Hee Ryu, et al.
American Journal of Hematology|June 16, 2007
Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in KoreaChanghoon Yoo, Min-Hee Ryu, Jooryung Huh, et al.
Annals of Surgical Oncology|November 1, 2024
Survival Outcomes According to NCCN Criteria for Resection Following Neoadjuvant Therapy for Patients with Localized Pancreatic CancerJong Keon Jang, Jae Ho Byun, Se Jin Choi, et al.
Future Oncology (London, England)|July 29, 2022
Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenibDong-Hoon Lim, Andrea Casadei-Gardini, Myung Ah Lee, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2016
Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumorChanghoon Yoo, Hyungwoo Cho, Min Jeong Song, et al.
Pageof 25